A Bisphosphonate Monoamide Analogue of DOTA: A Potential Agent for Bone Targeting
Authors:
- Vojtěch KubíčekVKVojtěch Kubíček
- Jakub RudovskýJRJakub Rudovský
- Jan KotekJKJan Kotek
- Petr HermannPHPetr Hermann
- Luce Vander ElstLELuce Vander Elst
- Robert N. MullerRMRobert N. Muller
- Zvonimir I. KolarZKZvonimir I. Kolar
- Hubert Th. WolterbeekHWHubert Th. Wolterbeek
- Joop A. PetersJPJoop A. Peters
- Ivan LukešILIvan Lukeš
- 4 November 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 127 (47) , 16477-16485
Abstract
A new macrocyclic DOTA-like ligand (BPAMD) for bone imaging and therapy containing a monoamide bis(phosphonic acid) bone-seeking group was designed and synthesized. Its lanthanide(III) complexes were prepared and characterized by 1H and 31P NMR spectroscopy. The Gd(III)−BPAMD complex was investigated in detail by 1H and 17O relaxometric studies to inspect parameters relevant for its potential application as an MRI contrast agent. Sorption experiments were conducted with Gd(III) and Tb(III) complexes using hydroxyapatite (HA) as a model of bone surface. Very effective uptake of the Gd−BPAMD complex by the HA surface was observed in NMR experiments. Radiochemical studies with the (160Tb−BPAMD)−HA system proved the sorption to be remarkably fast and strong on one hand and fully reversible on the other hand. The strong (Gd−BPAMD)−HA interaction was also supported by 1H NMRD measurements in the presence of a hydroxyapatite slurry, which showed an increase of the rotational correlation time upon adsorption of the complex on the HA surface, resulting in a significant relaxivity enhancement. The amide-bis(phosphonate) moiety is the only factor responsible for the binding of the complex to HA.Keywords
This publication has 25 references indexed in Scilit:
- Synthesis of a bifunctional monophosphinic acid DOTA analogue ligand and its lanthanide( iii ) complexes. A gadolinium( iii ) complex endowed with an optimal water exchange rate for MRI applicationsOrganic & Biomolecular Chemistry, 2004
- Silencing of Phosphonate-Gadolinium Magnetic Resonance Imaging Contrast by Hydroxyapatite BindingInvestigative Radiology, 2003
- Prototropic and Water-Exchange Processes in Aqueous Solutions of Gd(III) ChelatesAccounts of Chemical Research, 1999
- Synthesis of AminobisphosphonateSynthetic Communications, 1996
- Structural and Dynamic Parameters Obtained from 17O NMR, EPR, and NMRD Studies of Monomeric and Dimeric Gd3+ Complexes of Interest in Magnetic Resonance Imaging: An Integrated and Theoretically Self-Consistent Approach1Journal of the American Chemical Society, 1996
- Complexation of indium(III), gallium(III), iron(III), gadolinium(III), and neodymium(III) ions with amino diphosphonic acids in aqueous solutionInorganic Chemistry, 1993
- Phosphonate‐modified Gd‐DTPA complexes. III: The detection of myocardial infarction by MRIMagnetic Resonance in Medicine, 1993
- Phosphonate-Modified GdDTPA ComplexesInvestigative Radiology, 1991
- Phosphonate‐modified GdDTPA complexes. I. NMRD study of the solution behavior of new tissue‐specific contrast agentsMagnetic Resonance in Medicine, 1991
- Complexation of acetate and citrate anions with dysprosium (III) in aqueous solution as studied by oxygen‐17 NMR spectroscopyRecueil des Travaux Chimiques des Pays-Bas, 1978